Home :: Chronology of Committee Work

Chronology of Committee Work

2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997

Thursday, February 26, 2004

Drug Manufacturers Asked to Detail Relationships with NIH Scientists

In light of recent reports that top NIH scientists received consulting payments worth hundreds of thousands or even millions of dollars from drug manufacturers with an interest in their work, Reps. Waxman and Sherrod Brown write ten large pharmaceutical manufacturers – Merck, Johnson & Johnson, Wyeth, Schering-Plough, Pfizer, Bristol-MyersSquibb, Eli Lilly, Abbott, Amgen, and Allergan – to request information on their financial arrangements with NIH scientists.

Thursday, February 26, 2004

FDA Delays Consideration of Emergency Contraception Drug

Forty eight members of Congress write FDA about the delay in the consideration of the application for over-the-counter status for the emergency contraception drug Plan B.

Wednesday, February 25, 2004

USDA Urged to Support WIC Fruit and Vegetable Pilot Program

Reps. Waxman and Putnam urge USDA Secretary Veneman to support a pilot program to promote the consumption of fruits and vegetables in the upcoming reauthorization of the Federal Special Supplemental Nutrition Program for Woman, Infants, and Children.

Wednesday, February 25, 2004

Members Urge DOD to Submit Labor Plan Consistent with Intent of Congress

Rep. Waxman, along with Sens. Lieberman, Levin, Akaka, Durbin, and Reps. Skelton and Danny Davis, express serious concerns about an initial proposal for a new Defense Department labor relations system that effectively eliminates collective bargaining and makes changes to internal union procedures which have no relation to the Department’s national security mission.

Tuesday, February 24, 2004

Drug Benefits CEO May Have Helped Write Medicare Law Provisions

Reps. Waxman and Sherrod Brown write HHS Secretary Thompson, OMB Director Bolten, and White House Counsel Alberto Gonzales about reports that a pharmaceutical benefits management company CEO may have helped write provisions of the recent Medicare law that govern the prescription drug card program.

Tuesday, February 24, 2004

Halliburton Fuel Waiver Granted Under Suspect Circumstances

Reps. Waxman and Dingell ask the DOD IG to investigate the December 19 waiver given by the Corps of Engineers to Halliburton, citing new evidence that this unusual waiver -- which relieved Halliburton of its obligation to provide data to justify its high gasoline prices -- may have been awarded on false premises.

Thursday, February 19, 2004

Support for California Oyster Ban

Rep. Waxman urges Governor Schwarzenegger to maintain a life-saving ban on the summer sale of raw Gulf Coast Oysters.

Wednesday, February 18, 2004

Secret Service Questioned on White House Ricin Letter

Rep. Waxman asks about recent reports that the Secret Service waited six days to inform the U.S. Postal Service about the discovery of a ricin-contaminated letter addressed to the White House.

Tuesday, February 17, 2004

Washington State "Mad Cow" Walked on Day of Slaughter

Reps. Waxman and Tom Davis release eyewitness statements that the cow infected with BSE was not a “downer” cow, as has been claimed – calling into question USDA’s surveillance program for mad cow disease and the agency's credibility.

Thursday, February 12, 2004

Whistleblowers: Halliburton Routinely Overcharged

Two Kuwait-based former employees report that Halliburton systematically overpaid for goods and services and then passed these overcharges on to the U.S. taxpayer.

Thursday, February 12, 2004

EPA Questioned on Lobbyist Role in Mercury Rulemaking

Reps. Waxman and Allen ask for information on reports that portions of the latest air pollution control proposal may have been copied directly from industry lobbyist memos.

Tuesday, February 10, 2004

U.S. Role in Evacuating Saudi Citizens Questioned

Rep. Waxman asks about the Justice Department's role in evacuating members of the bin Laden family and other Saudi citizens in the aftermath of September 11, 2001.

Tuesday, February 10, 2004

President Urged to Ensure Cooperation with Leak Probe

Reps. Waxman and Conyers ask the President about reports that many White House officials are refusing to cooperate with the Justice Department's criminal investigation into the leak of the identity of a covert CIA operative.

Friday, February 06, 2004

Ephedra Substitutes May Pose Dangers

Stimulants sold as ephedra substitutes, not addressed by the pending FDA ban, may have adverse effects comparable to those of ephedra.

Thursday, February 05, 2004

Budget Asks for Fraction of Needed AIDS Funding Increase

Eight members call on the Administration to ensure that a new CDC initiative will not leave thousands of Americans with an HIV diagnosis but without access to life saving drugs.

Wednesday, February 04, 2004

H.R. 2138 Fails to Further Goal of Environmental Protection

Reps. Waxman and Tierney write Subcommittee on Energy Policy Chairman Ose on proposed legislation that would elevate the Environmental Protection Agency to cabinet-level status and makes significant changes to EPA's mission, structure, and authorities.

Tuesday, February 03, 2004

Administration Asked to Release Medicare Cost Estimates

Ranking Members Waxman, Rangel, and Dingell ask HHS to release cost estimates prepared by the Administration during congressional consideration of the Medicare prescription drug legislation.

Monday, February 02, 2004

Proposed Commission Lacks Adequate Independence

Rep. Pelosi, Sen. Daschle, Sen. Rockefeller, Rep. Waxman, and Sen. Lieberman urge the President to support a congressionally appointed commission to examine the intelligence used to justify the war in Iraq.

Friday, January 30, 2004

Supreme Court Urged to Consider Formal Recusal Process

Justice Scalia's refusal to recuse himself in the upcoming case involving Vice President Cheney's energy task force appears to conflict with the standard set in a 1996 case in which a federal judge was removed because of a friendship with former President Clinton.

Thursday, January 29, 2004

Members Asks for Investigation of DOD Handling of National Guard Case

Reps. Waxman, Clay, and Gephardt ask the Defense Department Inspector General to investigate whether a Republican state senator in Missouri who is also a member of the Missouri National Guard received special treatment from the Department of Defense.

Thursday, January 29, 2004

FDA Prescription Drug Ad Enforcement Declines Again

The new report prepared at the request of Rep. Waxman finds that FDA enforcement of provisions barring false and misleading advertisements has continued to decline.

Monday, January 26, 2004

Concerns About Commissioned Corps Reorganization Plan

Rep. Waxman and Chairman Davis write HHS to express concerns about the reorganization plan for the Commissioned Corps of the U.S. Public Health Service that appears to ignore valuable input from public health leaders and threaten the effectiveness of our nation's science-based agencies.

Monday, January 26, 2004

GAO Asked to Investigate White House Leak

House Democratic Leader Pelosi, Senate Democratic Leader Daschle, and Ranking Members Waxman, Lieberman, Rockefeller, and Conyers today request a GAO investigation into whether the White House complied with internal security procedures for protecting covert CIA operative Valerie Plame's identity from disclosure and responding to the leak after it occurred.

Saturday, January 24, 2004

Waxman Calls for Congressional Investigation of Halliburton Kickbacks

Rep. Waxman reveals that the Administration may have been informed of the kickbacks to Halliburton officials before awarding the company a new billion-dollar contract last week and calls for a congressional investigation of this and other issues related to Iraq reconstruction.

Friday, January 16, 2004

GAO Asked to Investigate Allegations on Consulting Payments to NIH Scientists

Reps. Waxman, Dingell, and Sherrod Brown ask GAO for an investigation into recent allegations that top NIH scientists received consulting payments, worth hundreds of thousands or even millions of dollars, from pharmaceutical manufacturers with an interest in their work.

Displaying Items 951 to 975 of 1351:

Previous PageNext Page

[1][2][3][4][5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22][23][24][25][26][27][28][29][30][31][32][33][34][35][36][37][38] • [39] • [40][41][42][43][44][45][46][47][48][49][50][51][52][53][54][55]